Patents by Inventor Philippe Millasseau

Philippe Millasseau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • G-CSF polypeptides and uses thereof
    Patent number: 7863018
    Abstract: The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: January 4, 2011
    Assignee: Merck Serono SA
    Inventors: Catherine Gonthier, Philippe Millasseau
  • G-CSF polypeptides and uses thereof
    Patent number: 7863016
    Abstract: The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: January 4, 2011
    Assignee: Merck Serono S.A.
    Inventors: Catherine Gonthier, Philippe Millasseau
  • G-CSF polypeptides and uses thereof
    Patent number: 7790174
    Abstract: The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: September 7, 2010
    Assignee: Merck Serono SA
    Inventors: Catherine Gonthier, Philippe Millasseau
  • G-CSF POLYPEPTIDES AND USES THEREOF
    Publication number: 20090275517
    Abstract: The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
    Type: Application
    Filed: June 26, 2009
    Publication date: November 5, 2009
    Applicant: MERCK SERONO S.A.
    Inventors: CATHERINE GONTHIER, PHILIPPE MILLASSEAU
  • G-CSF POLYPEPTIDES AND USES THEREOF
    Publication number: 20090275518
    Abstract: The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
    Type: Application
    Filed: June 26, 2009
    Publication date: November 5, 2009
    Applicant: Merck Serono S.A.
    Inventors: CATHERINE GONTHIER, Philippe Millasseau
  • G-CSF Polypeptides And Uses Thereof
    Publication number: 20080145377
    Abstract: The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
    Type: Application
    Filed: December 21, 2005
    Publication date: June 19, 2008
    Applicant: LABORATORIES SERONO S.A.
    Inventors: Catherine Gonthier, Philippe Millasseau
  • Method and apparatus for apportioning a primary volume of fluid into a determined number of secondary volumes having a predefined mutual relationship
    Patent number: 5241867
    Abstract: A method and apparatus for apportioning a primary volume of fluid into a plurality of secondary volumes having a predefined mutual relationship, by means of a chamber for receiving the primary volume of fluid having a bottom including fluid evacuation orifices (6) disposed in a common horizontal plane and connected to evacuation ducts (8) provided with cocks (19), enabling the beginning of fluid flow in the ducts (8) to be synchronized, with the end of said flow being determined by the free surface (26) of the fluid being fractioned by the evacuation orifices (6).
    Type: Grant
    Filed: May 11, 1992
    Date of Patent: September 7, 1993
    Assignee: Bertin et Cie
    Inventors: Daniel Cohen, Yves Le Gall, Jean Dausset, Philippe Millasseau, Isabelle Le Gall